Trulieve Cannabis Corp. (TRLV)
NYQ · Healthcare · Drug Manufacturers - Specialty & Generic
$10.92
-0.73%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.86B
Shares Outstanding
170.2M
P/S (TTM)
1.6x
Exchange
NYQ
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 288.2M | 293.1M | 286.8M | 271.0M |
| Gross Profit | 169.9M | 175.2M | 170.1M | 162.3M |
| Operating Income | 41.4M | 19.4M | 35.4M | 34.8M |
| Net Income | (26.8M) | (42.9M) | 2.4M | (406.0M) |
| Diluted EPS | $-0.14 | $-0.22 | $0.01 | $-2.10 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.2B | 1.2B |
| Gross Profit | 689.1M | 588.6M | 715.7M | 711.2M |
| Operating Income | 125.7M | 92.6M | 92.5M | 148.3M |
| Net Income | (246.1M) | (526.8M) | (155.1M) | (116.4M) |
| Diluted EPS | $-1.31 | $-2.79 | $-0.82 | $-0.61 |